Groowe Groowe / Newsroom / GILD
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

GILD News

Gilead Sciences Inc

Global Immunomodulators 2026-2031 - Rising Prevalence of Autoimmune Diseases Drives Market Growth

globenewswire.com
BMY NVS MRK AMGN PFE LLY BIIB AZN GILD ABBV TMO REGN IMUX

Global Cardiometabolic Drugs 2026-2031 - Rising Cardiometabolic Disease Prevalence Drives Market Growth

globenewswire.com
LLY NVO AZN BMY PFE MRK AMGN ABBV GILD

Flatiron Health Brings Three Research Acceptances to WCLC 2026

businesswire.com
AZN LLY GILD

New Jersey Legionella Law Creates Two Compliance Deadlines for Covered Buildings and Facilities

accessnewswire.com
ACGL AMZN CHTR PLD CCI EQIX IBM GOOGL MSFT AMAT NVDA INTC AMD MU SMCI PLTR CRSP BIIB REGN GILD MRNA TSLA NIO RIVN XOM CVX SHEL COP V MA JPM BAC WFC GS MS DIS CMCSA NFLX META PEP KO MCD SBUX WMT HD LOW COST TGT MDT ABBV PFE JNJ BMY LLY AZN NVO SNY AMGN VRTX GPRO GOOG CRM ADBE ORCL SAP CSCO QCOM TXN ADSK MELI BKNG EXPE MAR HLT IHG WYNN LVS MGM CCL RCL NCLH AAL UAL DAL LUV BA GD LMT RTX NOC HON GE MMM CAT DE BAX ISRG ROST TJX BBY BBWI SIRI TMUS VZ T QGEN ILMN ALGN EXAS IDXX TDOC ZBRA PTC DDOG PANW FTNT CRWD SNOW DD DOW ECL WTRG AWK XRAY SYK EW TMO ABT BSX BNTX NVAX VIR EDIT BEAM CRBU ARCT NVCR ALNY GPN PYPL COIN MPWR NXPI ON ROKU WDAY SNPS CDNS MCHP AEHR ASML KLAC LRCX ADI ANET CTAS PAYX ADP NOW TEAM DOCU ZS MDB PSTG ONTF VRSK VRSN ASO ULTA SE BABA JD PDD NTES BIDU IQ VIPS XP BEKE EDU RLX

GenBio AI met au point le premier modèle mondial de la cellule humaine

businesswire.com
MRNA GILD BMY AZN PFE JNJ REGN AMGN BIIB VRTX CRSP NTLA EDIT NVDA GOOG MSFT

The Galien Foundation Announces 2026 International Prix Galien Award Nominees

prnewswire.com
AZN MRK BMY GILD JNJ PFE REGN VRTX MED BFLY EW NVCR NVO IMCR

The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon

accessnewswire.com
NNVC GILD

Generic Injectables Market Research Report 2026 - Revenue to Reach $285.61 Billion by 2031, Driven by Patent Expirations and Biosimilar Growth

globenewswire.com
PFE BIIB AMGN REGN BMY GILD ABBV MRK JNJ BAX VTRS

Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer

globenewswire.com
GILD AZN AMGN

Trade Healthcare, Finance, and Consumer Giants on Zoomex

globenewswire.com
UNH GE JPM GILD REGN AMGN WMT KO PEP MA PYPL BRK.B AAPL TSLA NVDA